The U.S. Food and Drug Administration Advisory Board voted to support the provision of new crown vaccine booster shots for people over 65 years old

Summary

[U.S. Food and Drug Administration Advisory Committee voted to support the provision of new crown vaccine booster for people over 65]The U.S. Food and Drug Administration advisory board voted to support the provision of new crown vaccine booster for people over 65 years old and people at high risk of serious diseases. Previously, the committee voted against it to provide ordinary people with an application for enhanced needles. (China Business News)

The U.S. Food and Drug Administration’s advisory board voted to support the provision of new crown vaccine booster shots for people over 65 years of age and people at high risk of serious diseases. Previously, the committee voted against it to provide ordinary people with an application for enhanced needles.

Previously reported

The U.S. FDA expert panel rejects the plan to widely vaccinate Pfizer’s new crown vaccine booster

An expert advisory committee of the U.S. Food and Drug Administration (FDA) voted 16 to 2 against vaccinating people aged 16 and overPfizerThe new crown vaccine is intensified, but is willing to consider allowing a limited number of elderly and other susceptible people to be vaccinated. Some team members said that although they believe that the elderly or other more vulnerable groups may need booster vaccination, the demand for younger people may not be so urgent, and booster vaccination may bring other medical risks. The expert group is currently discussing reducing the scope of intensified vaccination.

(Source: China Business News)

Article source: China Business News

Editor in charge: DF537

Original title: The Advisory Board of the U.S. Food and Drug Administration voted to support the provision of new crown vaccine booster injections for people over 65 years of age